With its clinical and medical experts, the team of Innovative Molecules dedicates its work to patients suffering from herpes-mediated diseases.
While there has not been much medical improvement in the treatment of Herpes simplex disease over decades, the team aims to translate novel scientific findings into best-in-class therapies to improve current therapeutic regimens and helps patients in time of need.
Founded in 2016, Innovative Molecules is a German biotech focused on discovery, development and commercialization of novel agents in the field of herpes-mediated diseases.
The team has strong expertise in development and commercialization of medicines to help patients with debilitating disease around the globe.
Copyright © 2016 - 2023 Innovative Molecules. Developed by Workshop Agency